These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 18023284

  • 1. FXR signaling in metabolic disease.
    Zhang Y, Edwards PA.
    FEBS Lett; 2008 Jan 09; 582(1):10-8. PubMed ID: 18023284
    [Abstract] [Full Text] [Related]

  • 2. FXR, a target for different diseases.
    Wang YD, Chen WD, Huang W.
    Histol Histopathol; 2008 May 09; 23(5):621-7. PubMed ID: 18283647
    [Abstract] [Full Text] [Related]

  • 3. FXR: a metabolic regulator and cell protector.
    Wang YD, Chen WD, Moore DD, Huang W.
    Cell Res; 2008 Nov 09; 18(11):1087-95. PubMed ID: 18825165
    [Abstract] [Full Text] [Related]

  • 4. FXR, a multipurpose nuclear receptor.
    Lee FY, Lee H, Hubbert ML, Edwards PA, Zhang Y.
    Trends Biochem Sci; 2006 Oct 09; 31(10):572-80. PubMed ID: 16908160
    [Abstract] [Full Text] [Related]

  • 5. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
    Claudel T, Staels B, Kuipers F.
    Arterioscler Thromb Vasc Biol; 2005 Oct 09; 25(10):2020-30. PubMed ID: 16037564
    [Abstract] [Full Text] [Related]

  • 6. Nuclear bile acid receptor FXR in the hepatic regeneration.
    Chen WD, Wang YD, Meng Z, Zhang L, Huang W.
    Biochim Biophys Acta; 2011 Aug 09; 1812(8):888-92. PubMed ID: 21167938
    [Abstract] [Full Text] [Related]

  • 7. The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer.
    Sun L, Cai J, Gonzalez FJ.
    Nat Rev Gastroenterol Hepatol; 2021 May 09; 18(5):335-347. PubMed ID: 33568795
    [Abstract] [Full Text] [Related]

  • 8. Nuclear bile acid receptor FXR as pharmacological target: are we there yet?
    Modica S, Moschetta A.
    FEBS Lett; 2006 Oct 09; 580(23):5492-9. PubMed ID: 16904670
    [Abstract] [Full Text] [Related]

  • 9. MECHANISMS IN ENDOCRINOLOGY: FXR signalling: a novel target in metabolic diseases.
    Sonne DP.
    Eur J Endocrinol; 2021 May 09; 184(5):R193-R205. PubMed ID: 33630750
    [Abstract] [Full Text] [Related]

  • 10. The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.
    Cariou B.
    Diabetes Metab; 2008 Dec 09; 34(6 Pt 2):685-91. PubMed ID: 19195631
    [Abstract] [Full Text] [Related]

  • 11. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.
    Guo GL, Lambert G, Negishi M, Ward JM, Brewer HB, Kliewer SA, Gonzalez FJ, Sinal CJ.
    J Biol Chem; 2003 Nov 14; 278(46):45062-71. PubMed ID: 12923173
    [Abstract] [Full Text] [Related]

  • 12. [Farnesoid X receptor regulates glucose and lipid metabolisms].
    Jiang Q, Peng J, Liu SN, Shen ZF.
    Yao Xue Xue Bao; 2015 Mar 14; 50(3):245-51. PubMed ID: 26118101
    [Abstract] [Full Text] [Related]

  • 13. Bile acids and their signaling pathways: eclectic regulators of diverse cellular functions.
    Scotti E, Gilardi F, Godio C, Gers E, Krneta J, Mitro N, De Fabiani E, Caruso D, Crestani M.
    Cell Mol Life Sci; 2007 Oct 14; 64(19-20):2477-91. PubMed ID: 17876519
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Targeting farnesoid X receptor for liver and metabolic disorders.
    Fiorucci S, Rizzo G, Donini A, Distrutti E, Santucci L.
    Trends Mol Med; 2007 Jul 14; 13(7):298-309. PubMed ID: 17588816
    [Abstract] [Full Text] [Related]

  • 16. LXRS and FXR: the yin and yang of cholesterol and fat metabolism.
    Kalaany NY, Mangelsdorf DJ.
    Annu Rev Physiol; 2006 Jul 14; 68():159-91. PubMed ID: 16460270
    [Abstract] [Full Text] [Related]

  • 17. Deciphering the nuclear bile acid receptor FXR paradigm.
    Modica S, Gadaleta RM, Moschetta A.
    Nucl Recept Signal; 2010 Nov 19; 8():e005. PubMed ID: 21383957
    [Abstract] [Full Text] [Related]

  • 18. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I, Claudel T, Duval C, Kosykh V, Fruchart JC, Staels B.
    Mol Endocrinol; 2003 Feb 19; 17(2):259-72. PubMed ID: 12554753
    [Abstract] [Full Text] [Related]

  • 19. Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway.
    Fujino T, Murakami K, Ozawa I, Minegishi Y, Kashimura R, Akita T, Saitou S, Atsumi T, Sato T, Ando K, Hara S, Kikugawa K, Hayakawa M.
    FEBS J; 2009 Mar 19; 276(5):1319-32. PubMed ID: 19187229
    [Abstract] [Full Text] [Related]

  • 20. [Farnesoid X receptor (FXR): a novel regulative factor involved in metabolism].
    Zhang XY, Guan YF.
    Sheng Li Ke Xue Jin Zhan; 2007 Jul 19; 38(3):219-23. PubMed ID: 17882978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.